Demand is skyrocketing for Regeneron’s antibody cocktail, authorized by the Food and Drug Administration to treat COVID-19 symptoms in people who are at high risk of developing severe complications.
NPR’s Matthew Schwartz reports.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.